Tesofensine 500mcg x30 Capsules
Tesofensine
CAS: 195875-84-4
Tesofensine is a triple monoamine reuptake inhibitor (norepinephrine, dopamine, serotonin) originally developed for Parkinson and Alzheimer. Phase 2 obesity trials showed -10.6% weight loss at 0.5mg over 24 weeks — among the highest for a non-peptide compound. 99.0% HPLC purity.
Specifications
For laboratory research use only. Not for human consumption.
Mechanism of Action
Pre-synaptic inhibition of norepinephrine, dopamine, and serotonin reuptake transporters (NET/DAT/SERT). Produces sustained CNS appetite suppression and increased energy expenditure via monoamine elevation.
Research FAQ
What distinguishes Tesofensine from other weight loss compounds?
Tesofensine targets three monoamine transporters simultaneously (NET/DAT/SERT) rather than just one or two, producing broader central appetite suppression and thermogenic effects than single-transporter inhibitors.
